Pharmaceutical Process Scale-Up, 3rd Edition: Drug Development and Industrial Pharmacy

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Drug Development and Industrial Pharmacy

ISSN: 0363-9045 (Print) 1520-5762 (Online) Journal homepage: http://www.tandfonline.com/loi/iddi20

Pharmaceutical Process Scale-Up, 3rd edition

Linda A. Felton

To cite this article: Linda A. Felton (2012) Pharmaceutical Process Scale-Up, 3rd edition, Drug
Development and Industrial Pharmacy, 38:4, 512-512, DOI: 10.3109/03639045.2011.633523

To link to this article: https://doi.org/10.3109/03639045.2011.633523

Published online: 16 Nov 2011.

Submit your article to this journal

Article views: 173

View related articles

Full Terms & Conditions of access and use can be found at


http://www.tandfonline.com/action/journalInformation?journalCode=iddi20
Drug Development and Industrial Pharmacy, 2012; 38(4): 512
© 2012 Informa Healthcare USA, Inc.
ISSN 0363-9045 print/ISSN 1520-5762 online
DOI: 10.3109/03639045.2011.633523

Book Reviews

Pharmaceutical Process Scale-Up, 3rd edition perspective. Much of this chapter is focused on model-
Michael Levin, Editor based process optimization. Risk assessment and
Informa Healthcare, New York City, 2011 understanding risks during scale-up are discussed in
Chapter 3. This new chapter provides insight into assess-
The development of pharmaceutical products generally ing and controlling risk, focusing predominately on API
begins in a research laboratory where quantities of the manufacturing. Other notable new chapters cover pro-
active pharmaceutical ingredient (API) are limited and cess validation, scale up of continuous blending, and
quantities of product needed are small. For commer- virtual scale up of manufacturing processes. The updated
cial products, however, large quantities of materials are Appendices include internet links for FDA, EU, and ICH
required and significant problems may be encountered harmonization guidelines.
during this scale up phase of the drug development pro- As with the previous edition, much of the book is
cess. The text, Pharmaceutical Process Scale-Up, covers devoted to specific processes, such as powder blend-
both theoretical and practical aspects of ‘scaling up’ API ing and granulation, roller compaction, extrusion and
and drug product batch size. This is the third edition of spheronization, tableting, capsule filling, and coating.
the text, demonstrating the interest in the subject from Semi-solids, liquids, and parenterals are also covered.
the pharmaceutical industry. As with the previous edi- Overall, the book provides practical approaches for scal-
tion, the editor has compiled well known engineers and ing up of both drugs and drug products. This book will be
formulation scientists to author the chapters. valuable to formulation scientists, process engineers, and
The text begins with a chapter on dimensional analysis anyone else involved in scale up activities. The references
and scale up in theory as well as industrial application. to PAT, quality by design, and question-based review will
Simple examples are provided to demonstrate the theo- particularly appeal to validation and quality assurance
retical fundamentals of dimensional analysis, although personnel.
mathematically these examples become increasingly
complex. The next chapter focuses on process scale-up, Linda A. Felton, Ph.D.
validation, and optimization using process analytical University of New Mexico
technologies (PAT) and is written from an engineering College of Pharmacy

512

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy